The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taborda, C. P.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taborda, C. P.
Right arrow Articles by Casadevall, A.
The Journal of Immunology, 2003, 170: 3621-3630.
Copyright © 2003 by The American Association of Immunologists

More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG1

Carlos P. Taborda2,*, Johanna Rivera*, Oscar Zaragoza* and Arturo Casadevall3,*,{dagger}

* Department of Medicine, Division of Infectious Diseases, and {dagger} Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461

Despite a century of study, the relationship between Ag-specific Ig concentration and protection remains poorly understood for the majority of pathogens. In certain conditions, administration of high Ab doses before challenge with an infectious agent can be less effective than smaller Ab doses, a phenomenon which is consistent with a prozone-like effect. In this study, the relationship between IgG1, IgG2a, IgG2b, and IgG3 dose, infective inocula, and protection was investigated in a mouse model of Cryptococcus neoformans infection. The activity of each IgG subclass ranged from protective to disease-enhancing depending on both the Ab dose and infective inocula used. Enhanced dissemination to the brain was observed in mice given a high IgG2a dose and a relatively low inoculum. Ab administration had immunomodulatory effects, with cytokine expression in lung, brain, and spleen varying as a function of the infective inoculum Ab dose and IgG subclass. In vitro studies did not predict or explain the mechanism of in vivo prozone-like effects, because all isotypes were opsonic and elicited NO release from macrophages. IgG2a was most efficient in inducing a macrophage oxidative burst. These results reveal that an individual Ab can be protective, nonprotective, or disease-enhancing depending on its concentration relative to a challenge inoculum. Our findings have implications for the potential contribution of Ab responses to defense against microbial diseases because Ab-mediated immunity may be protective, nonprotective, or even deleterious to the host.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
A. J. Guimaraes, S. Frases, F. J. Gomez, R. M. Zancope-Oliveira, and J. D. Nosanchuk
Monoclonal Antibodies to Heat Shock Protein 60 Alter the Pathogenesis of Histoplasma capsulatum
Infect. Immun., April 1, 2009; 77(4): 1357 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. Spellberg, A. S. Ibrahim, M. R. Yeaman, L. Lin, Y. Fu, V. Avanesian, A. S. Bayer, S. G. Filler, P. Lipke, H. Otoo, et al.
The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus
Infect. Immun., October 1, 2008; 76(10): 4574 - 4580.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Buissa-Filho, R. Puccia, A. F. Marques, F. A. Pinto, J. E. Munoz, J. D. Nosanchuk, L. R. Travassos, and C. P. Taborda
The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB/c Mice Challenged Intratracheally with the Fungus
Infect. Immun., July 1, 2008; 76(7): 3321 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
O. Zaragoza, M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall
The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response
Infect. Immun., June 1, 2007; 75(6): 2729 - 2739.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Macura, T. Zhang, and A. Casadevall
Dependence of Macrophage Phagocytic Efficacy on Antibody Concentration
Infect. Immun., April 1, 2007; 75(4): 1904 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. O. Beenhouwer, E. M. Yoo, C.-W. Lai, M. A. Rocha, and S. L. Morrison
Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice against Cryptococcus neoformans Infection
Infect. Immun., March 1, 2007; 75(3): 1424 - 1435.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. R. Kozel, P. Thorkildson, S. Brandt, W. H. Welch, J. A. Lovchik, D. P. AuCoin, J. Vilai, and C. R. Lyons
Protective and Immunochemical Activities of Monoclonal Antibodies Reactive with the Bacillus anthracis Polypeptide Capsule
Infect. Immun., January 1, 2007; 75(1): 152 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Mulgrew, K. Kinneer, X.-T. Yao, B. K. Ward, M. M. Damschroder, B. Walsh, S.-Y. Mao, C. Gao, P. A. Kiener, S. Coats, et al.
Direct targeting of {alpha}v{beta}3 integrin on tumor cells with a monoclonal antibody, AbegrinTM
Mol. Cancer Ther., December 1, 2006; 5(12): 3122 - 3129.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
Z. Jalali, L. Ng, N. Singh, and L.-a. Pirofski
Antibody Response to Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan in Patients after Solid-Organ Transplantation.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 740 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. J. Sevilla, B. Robledo, A. Rementeria, M. D. Moragues, and J. Ponton
A Fungicidal Monoclonal Antibody Protects against Murine Invasive Candidiasis.
Infect. Immun., May 1, 2006; 74(5): 3042 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Y. Hamaguchi, Y. Xiu, K. Komura, F. Nimmerjahn, and T. F. Tedder
Antibody isotype-specific engagement of Fc{gamma} receptors regulates B lymphocyte depletion during CD20 immunotherapy
J. Exp. Med., March 20, 2006; 203(3): 743 - 753.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
K. Subramaniam, N. French, and L.-a. Pirofski
Cryptococcus neoformans-Reactive and Total Immunoglobulin Profiles of Human Immunodeficiency Virus-Infected and Uninfected Ugandans
Clin. Vaccine Immunol., October 1, 2005; 12(10): 1168 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Rivera and A. Casadevall
Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective Efficacy against Cryptococcus neoformans
J. Immunol., June 15, 2005; 174(12): 8017 - 8026.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. J. Brady
Antibody-Mediated Immunomodulation: a Strategy To Improve Host Responses against Microbial Antigens
Infect. Immun., February 1, 2005; 73(2): 671 - 678.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Rivera, O. Zaragoza, and A. Casadevall
Antibody-Mediated Protection against Cryptococcus neoformans Pulmonary Infection Is Dependent on B Cells
Infect. Immun., February 1, 2005; 73(2): 1141 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
B. C. Fries, E. Cook, X. Wang, and A. Casadevall
Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans
Antimicrob. Agents Chemother., January 1, 2005; 49(1): 350 - 357.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. T. Brandhorst, M. Wuthrich, B. Finkel-Jimenez, T. Warner, and B. S. Klein
Exploiting Type 3 Complement Receptor for TNF-{alpha} Suppression, Immune Evasion, and Progressive Pulmonary Fungal Infection
J. Immunol., December 15, 2004; 173(12): 7444 - 7453.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. W. Maitta, K. Datta, Q. Chang, R. X. Luo, B. Witover, K. Subramaniam, and L.-a. Pirofski
Protective and Nonprotective Human Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Manifest Different Specificities and Gene Use Profiles
Infect. Immun., August 1, 2004; 72(8): 4810 - 4818.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
O. Zaragoza and A. Casadevall
Antibodies Produced in Response to Cryptococcus neoformans Pulmonary Infection in Mice Have Characteristics of Nonprotective Antibodies
Infect. Immun., July 1, 2004; 72(7): 4271 - 4274.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. W. Maitta, K. Datta, A. Lees, S. S. Belouski, and L.-a. Pirofski
Immunogenicity and Efficacy of Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human Immunoglobulin Transgenic Mice
Infect. Immun., January 1, 2004; 72(1): 196 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. R. Kozel, R. S. MacGill, A. Percival, and Q. Zhou
Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan
Infect. Immun., January 1, 2004; 72(1): 209 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Burns, Z. Zhong, M. Steinitz, and L.-a. Pirofski
Modulation of Polymorphonuclear Cell Interleukin-8 Secretion by Human Monoclonal Antibodies to Type 8 Pneumococcal Capsular Polysaccharide
Infect. Immun., December 1, 2003; 71(12): 6775 - 6783.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Casadevall
Antibody-Mediated Immunity against Intracellular Pathogens: Two-Dimensional Thinking Comes Full Circle
Infect. Immun., August 1, 2003; 71(8): 4225 - 4228.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.